| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |